Storage-stable prostaglandin compositions
DC CAFCFirst Claim
Patent Images
1. An aqueous pharmaceutical composition comprising a therapeutically effective amount of a prostaglandin, a polyethoxylated castor oil in an amount effective to enhance the chemical stability of the prostaglandin, an antimicrobial preservative and a pharmaceutically acceptable vehicle, wherein the polyethoxylated castor oil is selected from the group consisting of PEG-5 to PEG-200 hydrogenated castor oils.
3 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The use of polyethoxylated castor oils in prostaglandin compositions enhances the prostaglandin'"'"'s chemical stability.
-
Citations
20 Claims
- 1. An aqueous pharmaceutical composition comprising a therapeutically effective amount of a prostaglandin, a polyethoxylated castor oil in an amount effective to enhance the chemical stability of the prostaglandin, an antimicrobial preservative and a pharmaceutically acceptable vehicle, wherein the polyethoxylated castor oil is selected from the group consisting of PEG-5 to PEG-200 hydrogenated castor oils.
- 12. A method of enhancing the chemical stability of an aqueous composition comprising a therapeutically-effective amount of a prostaglandin, wherein the method comprises adding a chemically-stabilizing amount of a polyethoxylated castor oil selected from the group of PEG-5 to PEG-200 hydrogenated castor oils to the composition.
Specification